NeutropeniaFebrile NeutropeniaChemotherapy-Induced Febrile NeutropeniaAntineoplastic Combined Chemotherapy ProtocolsFeverTaxoidsChemotherapy, AdjuvantDrug Administration ScheduleTreatment OutcomeGranulocyte Colony-Stimulating FactorCisplatinAntineoplastic AgentsPaclitaxelDoxorubicinNeoplasmsCyclophosphamideInfusions, IntravenousDeoxycytidineVinblastineDisease-Free SurvivalSurvival AnalysisCombined Modality TherapyAntineoplastic Agents, PhytogenicCamptothecinLung NeoplasmsCarboplatinAgranulocytosisBreast NeoplasmsSurvival RateMaximum Tolerated DoseEtoposideNeoplasm StagingFever of Unknown OriginMycosesIfosfamideOrganoplatinum CompoundsThrombocytopeniaHematologic DiseasesHematologic NeoplasmsDose-Response Relationship, DrugNeoadjuvant TherapyNeoplasm MetastasisLeukopeniaNauseaFluorouracilCarcinoma, Non-Small-Cell LungProspective StudiesAnthracyclinesEpirubicinBacterial InfectionsAntimetabolites, AntineoplasticPrognosisSalvage TherapyAnti-Bacterial AgentsNeoplasm Recurrence, LocalLymphoma, Non-HodgkinOpportunistic InfectionsMethotrexateTime FactorsVomitingAntibiotic ProphylaxisDrug Resistance, NeoplasmMucositisImmunocompromised HostFollow-Up StudiesRecurrencePenicillanic AcidOxonic AcidAdenocarcinomaTegafurAdministration, OralMitoxantroneLeucovorinDisease ProgressionBacteremiaLeukocyte CountEpisode of CareAntineoplastic Agents, AlkylatingOvarian NeoplasmsFeasibility StudiesBleomycinRetrospective StudiesDrug-Related Side Effects and Adverse ReactionsKaplan-Meier EstimatePlatinum CompoundsAntibiotics, AntineoplasticRecombinant ProteinsTopotecanBridged CompoundsAlopeciaGuanineInfectionAntifungal AgentsAntibodies, Monoclonal, HumanizedPiperacillinVincristineStomach NeoplasmsAmikacinColorectal NeoplasmsStomatitis